February 2012
2012-01-31 - 2012-02-01
Pharma & Biotech Patent Litigation in Amsterdam
Pharma and Biotech patent law continues to evolve rapidly, perhaps faster than patent law in any other field, with numerous significant case law developments arising from new tactics being employed by generics in recent times.
Read more …
2012-02-02 - 2012-02-03
2nd Annual EUCRAF Workshop in Freiburg, Germany
Following the particularly well received first workshop in 2011 on monoclonal antibodies the 2012 two-days’ networking event presents a unique speakers’ panel from various Agencies from Europe and Japan and from pharma companies. The mixture of currently hot regulatory and scientific themes is not only of interest for specialists from agencies and industry involved in the approval of new biopharmaceuticals but also for those who define the relevant strategy and development programmes.
Read more …
2012-02-17
5th Berlin Conference on IP in Life Sciences
Monoclonal antibodies are the fastest growing segment within the biotech and pharmaceutical industry. Today, four of the top ten selling blockbusters are antibodies. Industry forecasts see global antibody sales rising to $58bn in 2014.
Read more …
2012-02-23
Health Care Market India, Frankfurt am Main
How to shape your market strategy?
Read more …
